2-[(Z)-2-[3-(2-chloro-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[2-chloro-6-(trifluoromethoxy)-4-pyridinyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-(3-methyl-5-methylsulfonylphenyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;3-methyl-5-[1-[(Z)-2-(1,3,4-oxadiazol-2-yl)ethenyl]-1,2,4-triazol-3-yl]benzonitrile;2-[(Z)-2-[3-(2-methyl-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole

C83H68Cl2F6N34O11S — CID 161091308

IUPAC2-[(Z)-2-[3-(2-chloro-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[2-chloro-6-(trifluoromethoxy)-4-pyridinyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-(3-methyl-5-methylsulfonylphenyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;3-methyl-5-[1-[(Z)-2-(1,3,4-oxadiazol-2-yl)ethenyl]-1,2,4-triazol-3-yl]benzonitrile;2-[(Z)-2-[3-(2-methyl-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole
SMILESCC(C)Oc1cc(-c2ncn(/C=C\c3nnco3)n2)cc(Cl)n1.Cc1cc(-c2ncn(/C=C\c3nnco3)n2)cc(C(F)(F)F)c1.Cc1cc(-c2ncn(/C=C\c3nnco3)n2)cc(OC(C)C)n1.Cc1cc(-c2ncn(/C=C\c3nnco3)n2)cc(S(C)(=O)=O)c1.Cc1cc(C#N)cc(-c2ncn(/C=C\c3nnco3)n2)c1.FC(F)(F)Oc1cc(-c2ncn(/C=C\c3nnco3)n2)cc(Cl)n1
InChIInChI=1S/C15H16N6O2.C14H13ClN6O2.C14H10F3N5O.C14H10N6O.C14H13N5O3S.C12H6ClF3N6O2/c1-10(2)23-14-7-12(6-11(3)18-14)15-16-8-21(20-15)5-4-13-19-17-9-22-13;1-9(2)23-13-6-10(5-11(15)18-13)14-16-7-21(20-14)4-3-12-19-17-8-22-12;1-9-4-10(6-11(5-9)14(15,16)17)13-18-7-22(21-13)3-2-12-20-19-8-23-12;1-10-4-11(7-15)6-12(5-10)14-16-8-20(19-14)3-2-13-18-17-9-21-13;1-10-5-11(7-12(6-10)23(2,20)21)14-15-8-19(18-14)4-3-13-17-16-9-22-13;13-8-3-7(4-10(19-8)24-12(14,15)16)11-17-5-22(21-11)2-1-9-20-18-6-23-9/h4-10H,1-3H3;3-9H,1-2H3;2-8H,1H3;2-6,8-9H,1H3;3-9H,1-2H3;1-6H/b5-4-;4-3-;2*3-2-;4-3-;2-1-
InChIKeyUHFGYVWXJVKJJO-FRAOQORWSA-N
MW1934.64 g/mol
LogP15.23
Rot. Bonds24

About 2-[(Z)-2-[3-(2-chloro-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[2-chloro-6-(trifluoromethoxy)-4-pyridinyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-(3-methyl-5-methylsulfonylphenyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;3-methyl-5-[1-[(Z)-2-(1,3,4-oxadiazol-2-yl)ethenyl]-1,2,4-triazol-3-yl]benzonitrile;2-[(Z)-2-[3-(2-methyl-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole

2-[(Z)-2-[3-(2-chloro-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[2-chloro-6-(trifluoromethoxy)-4-pyridinyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-(3-methyl-5-methylsulfonylphenyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;3-methyl-5-[1-[(Z)-2-(1,3,4-oxadiazol-2-yl)ethenyl]-1,2,4-triazol-3-yl]benzonitrile;2-[(Z)-2-[3-(2-methyl-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole (PubChem CID 161091308) has the molecular formula C83H68Cl2F6N34O11S and a molecular weight of 1934.64 g/mol. Its IUPAC name is 2-[(Z)-2-[3-(2-chloro-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[2-chloro-6-(trifluoromethoxy)-4-pyridinyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-(3-methyl-5-methylsulfonylphenyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;3-methyl-5-[1-[(Z)-2-(1,3,4-oxadiazol-2-yl)ethenyl]-1,2,4-triazol-3-yl]benzonitrile;2-[(Z)-2-[3-(2-methyl-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole.

Molecular Properties

Compound Name2-[(Z)-2-[3-(2-chloro-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[2-chloro-6-(trifluoromethoxy)-4-pyridinyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-(3-methyl-5-methylsulfonylphenyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;3-methyl-5-[1-[(Z)-2-(1,3,4-oxadiazol-2-yl)ethenyl]-1,2,4-triazol-3-yl]benzonitrile;2-[(Z)-2-[3-(2-methyl-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole
PubChem CID161091308
Molecular FormulaC83H68Cl2F6N34O11S
Molecular Weight1934.64 g/mol
Exact Mass1932.48
IUPAC Name2-[(Z)-2-[3-(2-chloro-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[2-chloro-6-(trifluoromethoxy)-4-pyridinyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-(3-methyl-5-methylsulfonylphenyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;3-methyl-5-[1-[(Z)-2-(1,3,4-oxadiazol-2-yl)ethenyl]-1,2,4-triazol-3-yl]benzonitrile;2-[(Z)-2-[3-(2-methyl-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole
SMILESCC(C)Oc1cc(-c2ncn(/C=C\c3nnco3)n2)cc(Cl)n1.Cc1cc(-c2ncn(/C=C\c3nnco3)n2)cc(C(F)(F)F)c1.Cc1cc(-c2ncn(/C=C\c3nnco3)n2)cc(OC(C)C)n1.Cc1cc(-c2ncn(/C=C\c3nnco3)n2)cc(S(C)(=O)=O)c1.Cc1cc(C#N)cc(-c2ncn(/C=C\c3nnco3)n2)c1.FC(F)(F)Oc1cc(-c2ncn(/C=C\c3nnco3)n2)cc(Cl)n1
InChIInChI=1S/C15H16N6O2.C14H13ClN6O2.C14H10F3N5O.C14H10N6O.C14H13N5O3S.C12H6ClF3N6O2/c1-10(2)23-14-7-12(6-11(3)18-14)15-16-8-21(20-15)5-4-13-19-17-9-22-13;1-9(2)23-13-6-10(5-11(15)18-13)14-16-7-21(20-14)4-3-12-19-17-8-22-12;1-9-4-10(6-11(5-9)14(15,16)17)13-18-7-22(21-13)3-2-12-20-19-8-23-12;1-10-4-11(7-15)6-12(5-10)14-16-8-20(19-14)3-2-13-18-17-9-21-13;1-10-5-11(7-12(6-10)23(2,20)21)14-15-8-19(18-14)4-3-13-17-16-9-22-13;13-8-3-7(4-10(19-8)24-12(14,15)16)11-17-5-22(21-11)2-1-9-20-18-6-23-9/h4-10H,1-3H3;3-9H,1-2H3;2-8H,1H3;2-6,8-9H,1H3;3-9H,1-2H3;1-6H/b5-4-;4-3-;2*3-2-;4-3-;2-1-
InChIKeyUHFGYVWXJVKJJO-FRAOQORWSA-N
XLogP15.23
TPSA542.07 Ų
H-Bond Donors
H-Bond Acceptors45
Rotatable Bonds24
Heavy Atoms137
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001934.64
LogP ≤ 515.23
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1045

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze 2-[(Z)-2-[3-(2-chloro-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[2-chloro-6-(trifluoromethoxy)-4-pyridinyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-(3-methyl-5-methylsulfonylphenyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;3-methyl-5-[1-[(Z)-2-(1,3,4-oxadiazol-2-yl)ethenyl]-1,2,4-triazol-3-yl]benzonitrile;2-[(Z)-2-[3-(2-methyl-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(Z)-2-[3-(2-chloro-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[2-chloro-6-(trifluoromethoxy)-4-pyridinyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-(3-methyl-5-methylsulfonylphenyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;3-methyl-5-[1-[(Z)-2-(1,3,4-oxadiazol-2-yl)ethenyl]-1,2,4-triazol-3-yl]benzonitrile;2-[(Z)-2-[3-(2-methyl-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole?
The IUPAC name of 2-[(Z)-2-[3-(2-chloro-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[2-chloro-6-(trifluoromethoxy)-4-pyridinyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-(3-methyl-5-methylsulfonylphenyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;3-methyl-5-[1-[(Z)-2-(1,3,4-oxadiazol-2-yl)ethenyl]-1,2,4-triazol-3-yl]benzonitrile;2-[(Z)-2-[3-(2-methyl-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole (CID 161091308) is 2-[(Z)-2-[3-(2-chloro-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[2-chloro-6-(trifluoromethoxy)-4-pyridinyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-(3-methyl-5-methylsulfonylphenyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;3-methyl-5-[1-[(Z)-2-(1,3,4-oxadiazol-2-yl)ethenyl]-1,2,4-triazol-3-yl]benzonitrile;2-[(Z)-2-[3-(2-methyl-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole.
What is the SMILES notation for 2-[(Z)-2-[3-(2-chloro-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[2-chloro-6-(trifluoromethoxy)-4-pyridinyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-(3-methyl-5-methylsulfonylphenyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;3-methyl-5-[1-[(Z)-2-(1,3,4-oxadiazol-2-yl)ethenyl]-1,2,4-triazol-3-yl]benzonitrile;2-[(Z)-2-[3-(2-methyl-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole?
The canonical SMILES for 2-[(Z)-2-[3-(2-chloro-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[2-chloro-6-(trifluoromethoxy)-4-pyridinyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-(3-methyl-5-methylsulfonylphenyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;3-methyl-5-[1-[(Z)-2-(1,3,4-oxadiazol-2-yl)ethenyl]-1,2,4-triazol-3-yl]benzonitrile;2-[(Z)-2-[3-(2-methyl-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole is CC(C)Oc1cc(-c2ncn(/C=C\c3nnco3)n2)cc(Cl)n1.Cc1cc(-c2ncn(/C=C\c3nnco3)n2)cc(C(F)(F)F)c1.Cc1cc(-c2ncn(/C=C\c3nnco3)n2)cc(OC(C)C)n1.Cc1cc(-c2ncn(/C=C\c3nnco3)n2)cc(S(C)(=O)=O)c1.Cc1cc(C#N)cc(-c2ncn(/C=C\c3nnco3)n2)c1.FC(F)(F)Oc1cc(-c2ncn(/C=C\c3nnco3)n2)cc(Cl)n1.
What is the InChIKey of 2-[(Z)-2-[3-(2-chloro-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[2-chloro-6-(trifluoromethoxy)-4-pyridinyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-(3-methyl-5-methylsulfonylphenyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;3-methyl-5-[1-[(Z)-2-(1,3,4-oxadiazol-2-yl)ethenyl]-1,2,4-triazol-3-yl]benzonitrile;2-[(Z)-2-[3-(2-methyl-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole?
The InChIKey is UHFGYVWXJVKJJO-FRAOQORWSA-N. The full InChI is InChI=1S/C15H16N6O2.C14H13ClN6O2.C14H10F3N5O.C14H10N6O.C14H13N5O3S.C12H6ClF3N6O2/c1-10(2)23-14-7-12(6-11(3)18-14)15-16-8-21(20-15)5-4-13-19-17-9-22-13;1-9(2)23-13-6-10(5-11(15)18-13)14-16-7-21(20-14)4-3-12-19-17-8-22-12;1-9-4-10(6-11(5-9)14(15,16)17)13-18-7-22(21-13)3-2-12-20-19-8-23-12;1-10-4-11(7-15)6-12(5-10)14-16-8-20(19-14)3-2-13-18-17-9-21-13;1-10-5-11(7-12(6-10)23(2,20)21)14-15-8-19(18-14)4-3-13-17-16-9-22-13;13-8-3-7(4-10(19-8)24-12(14,15)16)11-17-5-22(21-11)2-1-9-20-18-6-23-9/h4-10H,1-3H3;3-9H,1-2H3;2-8H,1H3;2-6,8-9H,1H3;3-9H,1-2H3;1-6H/b5-4-;4-3-;2*3-2-;4-3-;2-1-.
What are the key properties of 2-[(Z)-2-[3-(2-chloro-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[2-chloro-6-(trifluoromethoxy)-4-pyridinyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-(3-methyl-5-methylsulfonylphenyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;3-methyl-5-[1-[(Z)-2-(1,3,4-oxadiazol-2-yl)ethenyl]-1,2,4-triazol-3-yl]benzonitrile;2-[(Z)-2-[3-(2-methyl-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole?
2-[(Z)-2-[3-(2-chloro-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[2-chloro-6-(trifluoromethoxy)-4-pyridinyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-(3-methyl-5-methylsulfonylphenyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;3-methyl-5-[1-[(Z)-2-(1,3,4-oxadiazol-2-yl)ethenyl]-1,2,4-triazol-3-yl]benzonitrile;2-[(Z)-2-[3-(2-methyl-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole has a molecular weight of 1934.64 g/mol, XLogP of 15.23, 24 rotatable bonds, 0 hydrogen bond donors, and 45 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(Z)-2-[3-(2-chloro-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[2-chloro-6-(trifluoromethoxy)-4-pyridinyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-(3-methyl-5-methylsulfonylphenyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;3-methyl-5-[1-[(Z)-2-(1,3,4-oxadiazol-2-yl)ethenyl]-1,2,4-triazol-3-yl]benzonitrile;2-[(Z)-2-[3-(2-methyl-6-propan-2-yloxy-4-pyridinyl)-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole;2-[(Z)-2-[3-[3-methyl-5-(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]ethenyl]-1,3,4-oxadiazole is sourced from PubChem (CID 161091308), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).